Immunome Inc. (IMNM)
NASDAQ · Healthcare
Immunome Inc. Revenue 2023–2025
Immunome Inc. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Immunome Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Immunome Inc. revenue for the twelve months ending March 31, 2026 was 6.9 M, a 29.66% decrease year-over-year.
- Immunome Inc. annual revenue for 2025 was 6.9 M, a 23.23% decrease from 2024.
- Immunome Inc. annual revenue for 2024 was 9.0 M, a 35.50% decrease from 2023.
- Immunome Inc. annual revenue for 2023 was 14.0 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Immunome Inc. Earnings — FAQ
Immunome Inc. (IMNM) earnings over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMNM's earnings history?
The chart and table above show Immunome Inc.'s earnings by year and by quarter, including the growth rate.